UHPLC Method Development for Determining Sitagliptin and Dapagliflozin in Lipid-Based Self-Nanoemulsifying Systems as Combined Dose in Commercial Products and its Application to Pharmacokinetic Study of Dapagliflozin in Rats
Crossref DOI link: https://doi.org/10.1007/s11094-019-01959-4
Published Online: 2019-04-12
Published Print: 2019-04-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kazi, Mohsin
Alqahtani, Abdulmohsen A.
Alsaadi, Badr S.
Alkholief, Musaed
Alanazi, Fars K.
Text and Data Mining valid from 2019-04-12
Version of Record valid from 2019-04-12
Article History
Received: 24 January 2018
First Online: 12 April 2019